CLEARWATER ANALYTICS HDS-A (CWAN) Stock Fundamental Analysis

NYSE:CWAN • US1851231068

22.82 USD
-0.33 (-1.43%)
Last: Feb 17, 2026, 01:47 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

5

CWAN gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 276 industry peers in the Software industry. Both the profitability and the financial health of CWAN get a neutral evaluation. Nothing too spectacular is happening here. CWAN shows excellent growth, but is valued quite expensive already.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

  • In the past year CWAN was profitable.
  • In the past year CWAN had a positive cash flow from operations.
  • CWAN had negative earnings in 4 of the past 5 years.
  • CWAN had a positive operating cash flow in 4 of the past 5 years.
CWAN Yearly Net Income VS EBIT VS OCF VS FCFCWAN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 0 200M -200M 400M

1.2 Ratios

  • With an excellent Return On Assets value of 13.12%, CWAN belongs to the best of the industry, outperforming 90.94% of the companies in the same industry.
  • With an excellent Return On Equity value of 19.79%, CWAN belongs to the best of the industry, outperforming 86.59% of the companies in the same industry.
  • With a Return On Invested Capital value of 0.01%, CWAN perfoms like the industry average, outperforming 55.80% of the companies in the same industry.
Industry RankSector Rank
ROA 13.12%
ROE 19.79%
ROIC 0.01%
ROA(3y)10.25%
ROA(5y)-1.97%
ROE(3y)11.01%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
CWAN Yearly ROA, ROE, ROICCWAN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 0 20 -20 40 60

1.3 Margins

  • Looking at the Profit Margin, with a value of 61.25%, CWAN belongs to the top of the industry, outperforming 94.20% of the companies in the same industry.
  • CWAN's Profit Margin has improved in the last couple of years.
  • CWAN has a Operating Margin of 0.04%. This is comparable to the rest of the industry: CWAN outperforms 55.80% of its industry peers.
  • In the last couple of years the Operating Margin of CWAN has declined.
  • Looking at the Gross Margin, with a value of 68.53%, CWAN is in line with its industry, outperforming 48.55% of the companies in the same industry.
  • In the last couple of years the Gross Margin of CWAN has remained more or less at the same level.
Industry RankSector Rank
OM 0.04%
PM (TTM) 61.25%
GM 68.53%
OM growth 3Y-37.9%
OM growth 5Y-35.42%
PM growth 3YN/A
PM growth 5Y82.95%
GM growth 3Y-0.14%
GM growth 5Y0.23%
CWAN Yearly Profit, Operating, Gross MarginsCWAN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 20 -20 40 60 80

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

4

2. Health

2.1 Basic Checks

  • CWAN has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • Compared to 1 year ago, CWAN has more shares outstanding
  • Compared to 5 years ago, CWAN has more shares outstanding
  • Compared to 1 year ago, CWAN has an improved debt to assets ratio.
CWAN Yearly Shares OutstandingCWAN Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M
CWAN Yearly Total Debt VS Total AssetsCWAN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.2 Solvency

  • CWAN has an Altman-Z score of 4.42. This indicates that CWAN is financially healthy and has little risk of bankruptcy at the moment.
  • Looking at the Altman-Z score, with a value of 4.42, CWAN is in the better half of the industry, outperforming 74.64% of the companies in the same industry.
  • The Debt to FCF ratio of CWAN is 10.26, which is on the high side as it means it would take CWAN, 10.26 years of fcf income to pay off all of its debts.
  • CWAN has a Debt to FCF ratio (10.26) which is comparable to the rest of the industry.
  • CWAN has a Debt/Equity ratio of 0.42. This is a healthy value indicating a solid balance between debt and equity.
  • CWAN has a Debt to Equity ratio of 0.42. This is in the lower half of the industry: CWAN underperforms 63.77% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.42
Debt/FCF 10.26
Altman-Z 4.42
ROIC/WACC0
WACC11%
CWAN Yearly LT Debt VS Equity VS FCFCWAN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 200M -200M 400M 600M 800M 1B

2.3 Liquidity

  • CWAN has a Current Ratio of 1.97. This is a normal value and indicates that CWAN is financially healthy and should not expect problems in meeting its short term obligations.
  • CWAN's Current ratio of 1.97 is in line compared to the rest of the industry. CWAN outperforms 56.88% of its industry peers.
  • CWAN has a Quick Ratio of 1.97. This is a normal value and indicates that CWAN is financially healthy and should not expect problems in meeting its short term obligations.
  • CWAN's Quick ratio of 1.97 is in line compared to the rest of the industry. CWAN outperforms 57.61% of its industry peers.
Industry RankSector Rank
Current Ratio 1.97
Quick Ratio 1.97
CWAN Yearly Current Assets VS Current LiabilitesCWAN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

10

3. Growth

3.1 Past

  • CWAN shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 23.81%, which is quite impressive.
  • The Earnings Per Share has been growing by 110.89% on average over the past years. This is a very strong growth
  • The Revenue has grown by 50.91% in the past year. This is a very strong growth!
  • CWAN shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 21.88% yearly.
EPS 1Y (TTM)23.81%
EPS 3YN/A
EPS 5Y110.89%
EPS Q2Q%16.67%
Revenue 1Y (TTM)50.91%
Revenue growth 3Y21.48%
Revenue growth 5Y21.88%
Sales Q2Q%77.08%

3.2 Future

  • The Earnings Per Share is expected to grow by 28.07% on average over the next years. This is a very strong growth
  • Based on estimates for the next years, CWAN will show a very strong growth in Revenue. The Revenue will grow by 27.52% on average per year.
EPS Next Y25.23%
EPS Next 2Y25.51%
EPS Next 3Y26.56%
EPS Next 5Y28.07%
Revenue Next Year63.93%
Revenue Next 2Y45.65%
Revenue Next 3Y35.86%
Revenue Next 5Y27.52%

3.3 Evolution

  • The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
CWAN Yearly Revenue VS EstimatesCWAN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 500M 1B 1.5B 2B 2.5B
CWAN Yearly EPS VS EstimatesCWAN Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 1 2 3

More info and screens

Find the best growth stocksShow best growing peers

2

4. Valuation

4.1 Price/Earnings Ratio

  • CWAN is valuated quite expensively with a Price/Earnings ratio of 43.88.
  • The rest of the industry has a similar Price/Earnings ratio as CWAN.
  • CWAN is valuated expensively when we compare the Price/Earnings ratio to 27.19, which is the current average of the S&P500 Index.
  • A Price/Forward Earnings ratio of 32.19 indicates a quite expensive valuation of CWAN.
  • The rest of the industry has a similar Price/Forward Earnings ratio as CWAN.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 28.06, CWAN is valued at the same level.
Industry RankSector Rank
PE 43.88
Fwd PE 32.19
CWAN Price Earnings VS Forward Price EarningsCWAN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

  • The rest of the industry has a similar Enterprise Value to EBITDA ratio as CWAN.
  • CWAN's Price/Free Cash Flow is on the same level as the industry average.
Industry RankSector Rank
P/FCF 81.79
EV/EBITDA 126.43
CWAN Per share dataCWAN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6

4.3 Compensation for Growth

  • The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
  • A more expensive valuation may be justified as CWAN's earnings are expected to grow with 26.56% in the coming years.
PEG (NY)1.74
PEG (5Y)0.4
EPS Next 2Y25.51%
EPS Next 3Y26.56%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • No dividends for CWAN!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

CLEARWATER ANALYTICS HDS-A

NYSE:CWAN (2/17/2026, 1:47:01 PM)

22.82

-0.33 (-1.43%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)11-05
Earnings (Next)02-18
Inst Owners99.01%
Inst Owner Change5.21%
Ins Owners0.84%
Ins Owner Change14.72%
Market Cap6.69B
Revenue(TTM)640.38M
Net Income(TTM)392.23M
Analysts73.75
Price Target26.49 (16.08%)
Short Float %4.14%
Short Ratio0.81
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-4.09%
Min EPS beat(2)-6.22%
Max EPS beat(2)-1.96%
EPS beat(4)2
Avg EPS beat(4)1.93%
Min EPS beat(4)-6.22%
Max EPS beat(4)13.33%
EPS beat(8)5
Avg EPS beat(8)5.62%
EPS beat(12)9
Avg EPS beat(12)8.6%
EPS beat(16)12
Avg EPS beat(16)8.35%
Revenue beat(2)1
Avg Revenue beat(2)0.59%
Min Revenue beat(2)-1.26%
Max Revenue beat(2)2.43%
Revenue beat(4)2
Avg Revenue beat(4)0.92%
Min Revenue beat(4)-1.26%
Max Revenue beat(4)3.06%
Revenue beat(8)4
Avg Revenue beat(8)0.21%
Revenue beat(12)7
Avg Revenue beat(12)0.28%
Revenue beat(16)9
Avg Revenue beat(16)0.28%
PT rev (1m)-9.43%
PT rev (3m)-16.07%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)-0.21%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.09%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.2%
Valuation
Industry RankSector Rank
PE 43.88
Fwd PE 32.19
P/S 10.45
P/FCF 81.79
P/OCF 73.22
P/B 3.38
P/tB 20646.54
EV/EBITDA 126.43
EPS(TTM)0.52
EY2.28%
EPS(NY)0.71
Fwd EY3.11%
FCF(TTM)0.28
FCFY1.22%
OCF(TTM)0.31
OCFY1.37%
SpS2.18
BVpS6.76
TBVpS0
PEG (NY)1.74
PEG (5Y)0.4
Graham Number8.89
Profitability
Industry RankSector Rank
ROA 13.12%
ROE 19.79%
ROCE 0.01%
ROIC 0.01%
ROICexc 0.01%
ROICexgc 0.03%
OM 0.04%
PM (TTM) 61.25%
GM 68.53%
FCFM 12.77%
ROA(3y)10.25%
ROA(5y)-1.97%
ROE(3y)11.01%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3Y-67.54%
ROICexgc growth 5Y-60.6%
ROICexc growth 3Y-68.91%
ROICexc growth 5Y-61.61%
OM growth 3Y-37.9%
OM growth 5Y-35.42%
PM growth 3YN/A
PM growth 5Y82.95%
GM growth 3Y-0.14%
GM growth 5Y0.23%
F-Score4
Asset Turnover0.21
Health
Industry RankSector Rank
Debt/Equity 0.42
Debt/FCF 10.26
Debt/EBITDA 13.9
Cap/Depr 16.09%
Cap/Sales 1.49%
Interest Coverage 0.02
Cash Conversion 152.85%
Profit Quality 20.85%
Current Ratio 1.97
Quick Ratio 1.97
Altman-Z 4.42
F-Score4
WACC11%
ROIC/WACC0
Cap/Depr(3y)83.6%
Cap/Depr(5y)112.55%
Cap/Sales(3y)1.75%
Cap/Sales(5y)1.82%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)23.81%
EPS 3YN/A
EPS 5Y110.89%
EPS Q2Q%16.67%
EPS Next Y25.23%
EPS Next 2Y25.51%
EPS Next 3Y26.56%
EPS Next 5Y28.07%
Revenue 1Y (TTM)50.91%
Revenue growth 3Y21.48%
Revenue growth 5Y21.88%
Sales Q2Q%77.08%
Revenue Next Year63.93%
Revenue Next 2Y45.65%
Revenue Next 3Y35.86%
Revenue Next 5Y27.52%
EBIT growth 1Y-97.99%
EBIT growth 3Y-24.56%
EBIT growth 5Y-21.29%
EBIT Next Year80.92%
EBIT Next 3Y44.09%
EBIT Next 5Y35.59%
FCF growth 1Y12.46%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y16.14%
OCF growth 3Y180.71%
OCF growth 5YN/A

CLEARWATER ANALYTICS HDS-A / CWAN FAQ

What is the ChartMill fundamental rating of CLEARWATER ANALYTICS HDS-A (CWAN) stock?

ChartMill assigns a fundamental rating of 5 / 10 to CWAN.


What is the valuation status for CWAN stock?

ChartMill assigns a valuation rating of 2 / 10 to CLEARWATER ANALYTICS HDS-A (CWAN). This can be considered as Overvalued.


What is the profitability of CWAN stock?

CLEARWATER ANALYTICS HDS-A (CWAN) has a profitability rating of 5 / 10.


Can you provide the financial health for CWAN stock?

The financial health rating of CLEARWATER ANALYTICS HDS-A (CWAN) is 4 / 10.